Cibc Private Wealth Group, LLC Neurocrine Biosciences Inc Transaction History
Cibc Private Wealth Group, LLC
- $51.4 Billion
- Q2 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 1,155 shares of NBIX stock, worth $139,997. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,155
Previous 7,627
84.86%
Holding current value
$139,997
Previous $1.05 Million
84.87%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NBIX
# of Institutions
641Shares Held
95.3MCall Options Held
661KPut Options Held
227K-
Black Rock Inc. New York, NY14.2MShares$1.72 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.22 Billion0.03% of portfolio
-
State Street Corp Boston, MA4.61MShares$559 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.47MShares$299 Million0.6% of portfolio
-
Jpmorgan Chase & CO New York, NY2.36MShares$286 Million0.03% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.6B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...